» Articles » PMID: 27995513

Progesterone Provides the Pleiotropic Neuroprotective Effect on Traumatic Brain Injury Through the Nrf2/ARE Signaling Pathway

Overview
Journal Neurocrit Care
Specialty Critical Care
Date 2016 Dec 21
PMID 27995513
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study was to investigate the role of Nrf2/ARE signaling pathway in the pleiotropic neuroprotective effect of progesterone (PROG) on traumatic brain injury (TBI).

Methods: The Nrf2-knockout (Nrf2-/-) and C57 mice were respectively subjected to a lateral cortical impact injury caused by a free-falling object and randomly divided into three groups: sham-operated, trauma, and trauma + PROG treatment group. The PROG treatment group was given PROG (32 mg/kg of body weight, intraperitoneal injection) immediately after injury. For all groups, a series of brain samples were obtained after trauma at 24 and 72 h, respectively. The cerebral edema was evaluated; the expression of IL-1β, IL-6, and TNF-α was measured using ELISA array, and the apoptosis index was detected by TUNEL. Flow cytometry was used to detect the intracellular calcium concentration.

Results: The water content, the apoptosis index, the levels of inflammatory cytokine, and the intracellular calcium ion were significantly decreased with the PROG treatment in C57 mice with TBI model. However, the effect of PROG on TBI was not found in the Nrf2-/- mouse model of TBI.

Conclusions: PROG reduced cerebral edema, apoptosis, inflammatory reaction, and intracellular calcium ion overload effects after TBI. These beneficial effects were not seen in the Nrf2-/- mouse model of TBI. The results from this study suggested that the Nrf2/ARE signal pathway may be involved in the pleiotropic neuroprotective effect of PROG on TBI.

Citing Articles

Evaluating the neuroprotective effects of progesterone receptors on experimental traumatic brain injury: The PI3K/Akt pathway.

Amirkhosravi L, Khaksari M, Amiresmaili S, Sanjari M, Khorasani P, Hashemian M Brain Behav. 2023; 13(11):e3244.

PMID: 37661235 PMC: 10636406. DOI: 10.1002/brb3.3244.


Neurosteroid Receptor Modulators for Treating Traumatic Brain Injury.

Verdoorn T, Parry T, Pinna G, Lifshitz J Neurotherapeutics. 2023; 20(6):1603-1615.

PMID: 37653253 PMC: 10684848. DOI: 10.1007/s13311-023-01428-7.


Effects of Progesterone on Preclinical Animal Models of Traumatic Brain Injury: Systematic Review and Meta-analysis.

Nasre-Nasser R, Severo M, Pires G, Hort M, Arbo B Mol Neurobiol. 2022; 59(10):6341-6362.

PMID: 35922729 DOI: 10.1007/s12035-022-02970-9.


AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin.

Badmann S, Mayr D, Schmoeckel E, Hester A, Buschmann C, Beyer S Sci Rep. 2022; 12(1):1862.

PMID: 35115586 PMC: 8814148. DOI: 10.1038/s41598-022-05785-9.


Edaravone Improves the Post-traumatic Brain Injury Dysfunction in Learning and Memory by Modulating Nrf2/ARE Signal Pathway.

Li X, Yu J, Ma D, Weng X Clinics (Sao Paulo). 2021; 76:e3131.

PMID: 34878029 PMC: 8610218. DOI: 10.6061/clinics/2021/e3131.


References
1.
Jaiswal A . Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic Biol Med. 2004; 36(10):1199-207. DOI: 10.1016/j.freeradbiomed.2004.02.074. View

2.
Pan D, Liu W, Yang X, Cao F . Inhibitory effect of progesterone on inflammatory factors after experimental traumatic brain injury. Biomed Environ Sci. 2008; 20(5):432-8. View

3.
Owuor E, Kong A . Antioxidants and oxidants regulated signal transduction pathways. Biochem Pharmacol. 2002; 64(5-6):765-70. DOI: 10.1016/s0006-2952(02)01137-1. View

4.
Zhao X, Sun G, Zhang J, Strong R, Dash P, Kan Y . Transcription factor Nrf2 protects the brain from damage produced by intracerebral hemorrhage. Stroke. 2007; 38(12):3280-6. DOI: 10.1161/STROKEAHA.107.486506. View

5.
Zhao J, Kobori N, Aronowski J, Dash P . Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents. Neurosci Lett. 2005; 393(2-3):108-12. DOI: 10.1016/j.neulet.2005.09.065. View